
    slow accrual
  
['head and neck cancer']
['docetaxel']

        Inclusion Criteria:

          -  Recurrent or second primary squamous cell head and neck cancer

          -  Defined area of recurrence on imaging

          -  Previous head and neck radiation (RT) to >/= 50 Gy

          -  Performance status score 0-1

          -  Time interval from previous RT >/= 9 months

          -  Volume of disease appropriate for protocol treatment

          -  Minimum estimated survival of >/= 3 months

          -  Age >/= 18

          -  Adequate labs

        Exclusion Criteria:

          -  Primary tumors of the salivary gland

          -  Original pathology report and radiation therapy records not available

          -  Prior spinal cord dose > 45 Gy

          -  Surgery or chemotherapy within 4 weeks

          -  Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free
             for a minimum of 3 years; noninvasive cancers are permitted
      